Amylyx Pharmaceuticals, Inc. Common Stock vs. Eli Lilly & Co.
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| AMLX | LLY | |
|---|---|---|
| Market Cap | $3.79 billion | $1.28 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| AMLX | LLY | |
|---|---|---|
| Dividend Yield | 5.69% | 0.48% |
AMLX leads on 1 of 1 dividend factors.
Risk & Sentiment
| AMLX | LLY | |
|---|---|---|
| Short Interest | 0.00% | 1.29% |
AMLX leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMLX overview, AMLX financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
